Not available
Quote | CytomX Therapeutics Inc. (NASDAQ:CTMX)
Last: | $1.32 |
---|---|
Change Percent: | 0.75% |
Open: | $1.32 |
Close: | $1.32 |
High: | $1.39 |
Low: | $1.28 |
Volume: | 1,468,032 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | CytomX Therapeutics Inc. (NASDAQ:CTMX)
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a firesid...
2024-06-17 16:31:49 ET More on CytomX CytomX: CX-904 Tumor Treatment Data Might Get Ball Rolling CytomX Therapeutics: I'm Bullish; There's More Than One Masked Immunotherapy Company In Town Read the full article on Seeking Alpha For further details see: C...
Message Board Posts | CytomX Therapeutics Inc. (NASDAQ:CTMX)
Subject | By | Source | When |
---|---|---|---|
Price gaining up | alstocks | investorshub | 06/28/2023 3:51:30 PM |
$CTMX and the shorts continue | alstocks | investorshub | 06/28/2023 8:32:04 AM |
Price trading up | TheFinalCD | investorshub | 06/24/2023 9:54:22 AM |
$CTMX MomentumIts now | Triple nickle | investorshub | 06/23/2023 4:28:00 AM |
MomentumIts gaining up | alexjames81 | investorshub | 06/20/2023 8:24:35 PM |
News, Short Squeeze, Breakout and More Instantly...
CytomX Therapeutics Inc. Company Name:
CTMX Stock Symbol:
NASDAQ Market:
CytomX Therapeutics Inc. Website:
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a firesid...
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024. “Chris has mad...